Tripon S, Bilbault P, Fabacher T, Lefebvre N, et al. Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19. Clin Res Hepatol Gastroenterol 2022;46:101894.
PMID: 35227956